Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment
Frontiers in Oncology · 19.05.2026 · 16
DOI: 10.3389/fonc.2026.1855583 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Oncology, online erschienen am 19.05.2026. Verfasst von Purvi Purohit und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences Jodhpur, Jodhpur, India. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, All India Institute of Medical Sciences Jodhpur, Jodhpur, India.
- Department of Medical Oncology, Gujarat Technological University, Ahmedabad, India.
Zitieren
APA
Purohit, P., Kumar, P., & Modi, A. (2026). Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1855583
Vancouver
Purohit P, Kumar P, Modi A. Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1855583
BibTeX
@article{Purohit2026,
author = {Purohit, Purvi and Kumar, Parmod and Modi, Anupama},
title = {Editorial: Epigenomics and metabolomics: pioneering new frontiers in breast cancer research and treatment},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1855583}
}
EUVIMED